Los Angeles S&T Newsletter #33 - December 2012


By now, the world is relatively well aware of the devastating retrovirus HIV, the causing agent of AIDS, but its discovery and recognition still lie in the relatively recent past. In fact, May 2013 will mark the 30 year anniversary since the first official publication in Science on the “human immunodeficiency virus.” In the time that has passed since it was first reported, tremendous strides have been made in research into and treatment of the virus. However, the fight is far from over. In honor of these achievements and in recognition of the remaining work to be done, the Institut Pasteur, in collaboration with the U.S. National Institutes of Health, ANRS and sidaction, is organizing an international symposium “30 years of HIV science : Imagine the future” to be held at the Institut Pasteur in Paris. Rather than reflect on the history of the virus, the symposium will highlight critical challenges that today’s scientists face as well as the priorities they must have for the future of HIV treatment. International speakers will include senior scientists, young investigators, students and researchers who will share their respective findings and visions for the future. For more information on the event, please visit www.pasteur.fr/30yearsHIV.

Kara Leary, Science and Technology Intern
Aurelie Perthuison, Deputy Attaché for Science and Technology
Fabien Agenes, Attaché for Science and Technology



November 6, 2012 : Breast cancer and depression : UCLA gets $5M to study why survivors are at such high risk

UCLA researchers have received a $5 million grant from the National Cancer Institute for a study aimed at developing a risk profile for breast cancer survivors likely to suffer from depression. The prevalence of depression among survivors is three to five times greater than in the general population. UCLA will be teaming on the five-year study with Kaiser Permanente, which will provide the 300 volunteers needed for the study by culling through electronic patient records to locate women who have been treated for breast cancer and have not had a history of depression.

To access the full article :

November 7, 2012 : McMahon installed as chair of stem cell biology

Andrew McMahon, newly appointed chair of the Department of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine of USC and director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, is often asked why he left the Harvard Stem Cell Institute to come here. He offered one simple word of explanation : opportunity. “I wanted the opportunity to create something special within the emerging field of regenerative medicine,” McMahon said. “The energy and excitement of Los Angeles provides a wonderful bonus, but this was a decision deeply rooted in my training, interests and experience over 35 years and my desire to translate these things into something of great significance in a first-class university.”

To access the full article :

November 7, 2012 : New cell type developed for possible treatment of Alzheimer’s and other brain diseases

UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimer’s. Dr. Edwin Monuki of UCI’s Sue & Bill Gross Stem Cell Research Center, developmental & cell biology graduate student Momoko Watanabe and colleagues developed these cells — called choroid plexus epithelial cells — from existing mouse and human embryonic stem cell lines. CPECs are critical for proper functioning of the choroid plexus, the tissue in the brain that produces cerebrospinal fluid. Among their various roles, CPECs make CSF and remove metabolic waste and foreign substances from the fluid and brain.

To access the full article :

November 7, 2012 : Tiny telescope improves focus

Ask most people to describe a telescope and they might imagine a large device in an observatory training its penetrating gaze into outer space. Don Mason has one implanted in his right eye. He’s among the first patients in the country to receive a pea-sized telescope designed to partially restore vision in those with age-related macular degeneration. “Macular degeneration damages the retina and causes a blind spot in the center of a person’s field of vision,” says Dr. Sumit “Sam” Garg, medical director of UC Irvine’s Gavin Herbert Eye Institute. “The implantable miniature telescope projects an image onto an undamaged portion of the retina, making it possible for patients to recognize faces, read and perform daily activities.”

To access the full article :

November 8, 2012 : Innovative Approach to Treating Intestinal Roundworms Holds Hope for Millions of Infected Children in Undeveloped Regions

For billions of people, mostly in poor, undeveloped regions, intestinal roundworms are a debilitating fact of life. These parasites, which include hookworms and whipworms, infect four million children, causing stunted growth, poor mental development and malnutrition. They also have a major impact on the health of pregnant women and other adults. Delivering or developing expensive anti-roundworm treatments to billions of people in the Third World isn’t a practical solution. But an innovative idea by a UC San Diego biologist to develop strains of bacteria that possess a crystalline protein toxic to intestinal roundworms that can be easily eaten in yogurt and soybean dishes could offer hope.

To access the full article :

November 8, 2012 : Comet collisions every six seconds explain 17-year-old stellar mystery

Every six seconds, for millions of years, comets have been colliding with one another near a star in the constellation Cetus called 49 CETI, which is visible to the naked eye. Over the past three decades, astronomers have discovered hundreds of dusty disks around stars, but only two — 49 CETI is one — have been found that also have large amounts of gas orbiting them. Young stars, about a million years old, have a disk of both dust and gas orbiting them, but the gas tends to dissipate within a few million years and almost always within about 10 million years. Yet 49 CETI, which is thought to be considerably older, is still being orbited by a tremendous quantity of gas in the form of carbon monoxide molecules, long after that gas should have dissipated.

To access the full article :

November 13, 2012 : Brain cancer breakthrough

UC Irvine oncologists are looking for new ways to treat glioblastoma multiforme, the deadliest type of brain cancer. While surgery followed by chemotherapy and radiation is the current standard of care, it doesn’t fully eliminate the cancer. The goal is to develop an additional therapy that seeks out and destroys the cancer cells that inevitably remain. Dr. Daniela Bota is testing whether enlisting the immune system to fight the tumor can complement surgery, drugs and radiation and improve a patient’s odds of surviving. Nearly 14,000 Americans are diagnosed each year with glioblastoma multiforme, and only 10 percent will survive more than five years, according to the National Cancer Institute.

To access the full article :

November 14, 2012 : Air pollutants linked to diminished brain function of seniors

At first, USC’s large, interdisciplinary series of studies into air pollution and brain health seemed outside the wheelhouse of Jennifer Ailshire, a sociologist, demographer and postdoctoral student at the USC Davis School of Gerontology. After University Professor Caleb Finch tapped her to contribute to the massive project, however, she found an unexpected and extremely valuable niche. By conducting the first study to show how exposure to air pollution influences cognitive function in a national sample of older men and women, Ailshire found that living in areas of high air pollution is indeed an environmental risk to seniors’ brain health.

To access the full article :

November 14, 2012 : New global subsidy that provides access to most effective malaria drugs shows promise

A new international program, conceived in part by a UCLA physician, has rapidly transformed access to lifesaving anti-malarial drugs by providing cheap, subsidized artemisinin-based combination therapies in seven African countries that account for a quarter of the world’s malaria cases. The first independent evaluation of the Affordable Medicines Facility–malaria (AMFm) program was recently published in the journal The Lancet. The program is based at the Global Fund in Geneva, an international financing institution dedicated to disbursing funds to prevent and treat infectious diseases.

To access the full article :

November 15, 2012 : Researchers report potential new treatment to stop Alzheimer’s disease

Last March, researchers at UCLA reported the development of a molecular compound called CLR01 that prevented toxic proteins associated with Parkinson’s disease from binding together and killing the brain’s neurons. Building on those findings, they have now turned their attention to Alzheimer’s disease, which is thought to be caused by a similar toxic aggregation or clumping, but with different proteins, especially amyloid-beta and tau. And what they’ve found is encouraging. Using the same compound, which they’ve dubbed a "molecular tweezer," in a living mouse model of Alzheimer’s, the researchers demonstrated for the first time that the compound safely crossed the blood–brain barrier, cleared the existing amyloid-beta and tau aggregates, and also proved to be protective to the neurons’ synapses — another target of the disease — which allow cells to communicate with one another.

To access the full article :

November 15, 2012 : Toward the 3D Virtual Cell : UC San Diego to Host Dec. 13-14 Conference

The 3D Virtual Cell could do for cell biology what the Large Hadron Collider has done for particle physics. But instead of building a multi-billion-dollar facility, backers of the 3D Virtual Cell project believe they can build a virtual, rather than physical, resource that could be used by biologists and medical researchers for generations to come. With support from the National Science Foundation (NSF), the University of California, San Diego will launch a year-long series of workshops, beginning with “Toward the 3D Virtual Cell,” a conference set to take place Dec. 13-14, 2012, at the California Institute for Telecommunications and Information Technology (Calit2) on the UC San Diego campus.

To access the full article :

November 19, 2012 : Human Brain, Internet, and Cosmology : Similar Laws at Work ?

The structure of the universe and the laws that govern its growth may be more similar than previously thought to the structure and growth of the human brain and other complex networks, such as the Internet or a social network of trust relationships between people, according to a new paper published in the science journal Nature’s Scientific Reports. “By no means do we claim that the universe is a global brain or a computer,” said Dmitri Krioukov, co-author of the paper, published by the Cooperative Association for Internet Data Analysis (CAIDA), based at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego. “But the discovered equivalence between the growth of the universe and complex networks strongly suggests that unexpectedly similar laws govern the dynamics of these very different complex systems.”

To access the full article :

November 19, 2012 : A test of nerves

Thomas Lane looks anything but the typical scientist as he strides through his lab at UC Irvine’s Sue & Bill Gross Stem Cell Research Center sporting shorts, a T-shirt and loafers. Walking past research assistants hunkered over microscopes and test tubes, he pauses to show off his prized possessions : 1970s posters of the Cincinnati Reds that once adorned his bedroom in his hometown of Muncie, Ind. That’s the thing about Lane : He’s just as comfortable talking sports as he is discussing stem cells. He loves baseball, swam competitively in high school and college, and is an avid surfer. In short, he’s a regular guy — who has made extraordinary gains in UCI’s battle against a devastating disorder with no known cure.

To access the full article :

November 26, 2012 : UCLA performs first ’breathing lung’ transplant in United States

First there was the "heart in a box," a revolutionary experimental technology that allows donor hearts to be delivered to transplant recipients warm and beating rather than frozen in an ice cooler. Now that same technology is being used to deliver "breathing lungs." The lung transplant team at Ronald Reagan UCLA Medical successfully performed the nation’s first "breathing lung" transplant in mid-November. The patient, a 57-year-old who suffered from pulmonary fibrosis — a disease in which the air sacs of the lungs are gradually replaced by scar tissue — received two new lungs and is recuperating from the seven-hour surgery.

To access the full article :

November 27, 2012 : New behavioral strategies may help patients learn to better control chronic diseases

One of the most important health problems in the United States is the failure of patients with chronic diseases to take their medications and do all that is necessary to control their illnesses. In a study published in the current Journal of General Internal Medicine, UCLA researchers and their colleagues suggest that physicians take a serious look at tools and strategies used in behavioral economics and social psychology to help motivate their patients to assert better control over chronic diseases. Breaking large goals into smaller, more manageable parts, for example, may help patients better manage diseases such as diabetes, the researchers say.

To access the full article :

November 27, 2012 : Pioneering Electrical Engineering Work Recognized

Alexander A. Balandin, a professor of electrical engineering in the Bourns College of Engineering and founding chair of materials science and engineering at the University of California, Riverside has been named an IEEE Fellow for 2013. IEEE is the world’s leading professional organization for advancing technology for humanity. Balandin, who is also the recipient of IEEE Pioneer of Nanotechnology Award for 2011, is being recognized for his contributions to the characterization of thermo-electric properties of semiconductor nanostructures and graphene, a material that could play a major role in keeping laptops and other electronic devices from overheating.

To access the full article :

November 27, 2012 : Students Build Mobile Solar Power System

Students from the University of California, Riverside’s Bourns College of Engineering have designed and built a mobile solar power system aimed to provide clean energy everywhere from on-campus concerts to national parks or forests where scientists are conducting fieldwork. The mobile solar power system, a sustainable alternative to a diesel- or gasoline-powered generator, is an 18-foot trailer with six solar panels, a wind turbine and eight rechargeable batteries, each of which is several times larger than a car battery, which store the energy for use when there is no sunlight.

To access the full article :

November 27, 2012 : USC’s therapy disciplines meet to discuss research

The recent USC Occupational Therapy and Physical Therapy Forum brought together students and faculty from USC’s top-ranked therapy professions for an evening of interdisciplinary learning and collaborative problem-solving. The event was hosted as a joint effort between Pi Theta Epsilon, the USC chapter of the national occupational therapy student honor society, and the USC Physical Therapy Student Association. The evening began with an informal viewing of research posters displaying current studies and publications by faculty, staff and students.

To access the full article :

November 28, 2012 : High fructose corn syrup linked to diabetes

A new study by USC and University of Oxford researchers indicates that large amounts of high fructose corn syrup (HFCS) found in national food supplies across the world may be one explanation for the rising global epidemic of Type 2 diabetes and resulting higher health care costs. According to the study, which was published in Global Public Health, countries that use HFCS in their food supply had a 20 percent higher prevalence of diabetes than countries that did not use it. The analysis also revealed that the HFCS association with the “significantly increased prevalence of diabetes” occurred independent of total sugar intake and obesity levels.

To access the full article :

November 28, 2012 : Scientists Identify Two Transposons That Are Active in Human Cells

Transposable elements — or transposons — are DNA sequences that move in the genome from one location to another. Discovered in the 1940s, for years they were thought to be unimportant and were called “junk DNA.” But now scientists recognize that these bits of DNA play vital roles in gene and genome evolution, and are important genetic tools for genome engineering. A group of scientists recently identified two transposable elements — TcBuster and Space Invader — that are highly active in human cells, offering powerful genetic tools for mammalian genome engineering.

To access the full article :


November 2, 2012 : FDA expands use of Xarelto to treat, reduce recurrence of blood clots

The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment. Blood clots occur when blood thickens and clumps together. DVT is a blood clot that forms in a vein deep in the body. Most deep vein blood clots occur in the lower leg or thigh. When a blood clot in a deep vein breaks off and travels to an artery in the lungs and blocks blood flow, it results in a potentially deadly condition called PE.

To access the full article :

November 5, 2012 : Therapy with bone marrow-derived stem cells does not improve short-term recovery after heart attack

Administering to patients stem cells derived from their own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health. The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME), mirror a previous, related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did not improve heart function. Both TIME and LateTIME were conducted by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH’s National Heart, Lung, and Blood Institute.

To access the full article :

November 7, 2012 : MRI and EEG could identify children at risk for epilepsy after febrile seizures

Seizures during childhood fever are usually benign, but when prolonged, they can foreshadow an increased risk of epilepsy later in life. Now a study funded by the National Institutes of Health suggests that brain imaging and recordings of brain activity could help identify the children at highest risk. The study reveals that within days of a prolonged fever-related seizure, some children have signs of acute brain injury, abnormal brain anatomy, altered brain activity, or a combination.

To access the full article :

November 8, 2012 : HPV vaccine may benefit HIV-infected women

Women with HIV may benefit from a vaccine for human papillomavirus (HPV), despite having already been exposed to HPV, a study finds. Although many may have been exposed to less serious forms of HPV, more than 45 percent of sexually active young women who have acquired HIV appear never to have been exposed to the most common high-risk forms of HPV, according to the study from a National Institutes of Health research network. HPV is the most common sexually transmitted infection in the world. The virus can infect the anal and genital areas, mouth and throat of males and females. High-risk forms of the virus can cause cancer, including cancer of the cervix.

To access the full article :

November 12, 2012 : HHS announces first external class of the HHS Innovation Fellows Program

Today, Health and Human Services (HHS) Secretary Kathleen Sebelius announced the first class of the HHS External Innovation Fellows. Selected from an applicant pool of more than 100 innovators, the six External Fellows will spend the next six to 12 months working on projects focused on solving critical health care problems. The External Fellows announced today have backgrounds ranging from business and technology executives to lifelong entrepreneurs.

To access the full article :

November 14, 2012 : PCBs, other pollutants may play role in pregnancy delay

Couples with high levels of PCBs and similar environmental pollutants take longer to achieve pregnancy in comparison to other couples with lower levels of the pollutants, according to a preliminary study by researchers at the National Institutes of Health and other institutions. PCBs (polychlorinated biphenyls) are chemicals that have been used as coolants and lubricants in electrical equipment. They are part of a category of chemicals known as persistent organochlorine pollutants and include industrial chemicals and chemical byproducts as well as pesticides. In many cases, the compounds are present in soil, water, and in the food chain.

To access the full article :

November 18, 2012 : Research breakthrough selectively represses the immune system

In a mouse model of multiple sclerosis (MS), researchers funded by the National Institutes of Health have developed innovative technology to selectively inhibit the part of the immune system responsible for attacking myelin—the insulating material that encases nerve fibers and facilitates electrical communication between brain cells. Autoimmune disorders occur when T-cells—a type of white blood cell within the immune system—mistake the body’s own tissues for a foreign substance and attack them. Current treatment for autoimmune disorders involves the use of immunosuppressant drugs which tamp down the overall activity of the immune system.

To access the full article :

November 19, 2012 : Brain Wave Synchronization Key to Working Visual Memory

Short-term memories are stored as synchronized signals between 2 key brain hubs, according to a new study in monkeys. The findings show for the first time how the brain stores visual information for working memory tasks. Working memory is the ability to hold information in mind and quickly process that information in order to act on it. The visual working memory system has been extensively studied in monkeys and humans. Previous research showed that 2 brain areas, the prefrontal cortex and the parietal cortex, are activated when working memory is used. Electrical signals between neurons in this circuit become synchronized during an identity-matching task in which the subject is asked to match a previously seen object after a time delay.

To access the full article :

November 19, 2012 : Cataloging Human Genetic Variation

The world’s largest, most detailed catalog of human genetic variation—used by disease researchers around the world—has more than doubled in size. The newly published information will provide deeper insights into the genomic basis of human disease. Genetically, people are more than 99% alike. Although most of the variations between us have little or no effect, others can contribute to disease. The goal of the 1000 Genomes Project is to identify and compile variants in the human genome that are harbored by at least 1 in 50 people. NIH’s National Human Genome Research Institute (NHGRI) helps fund and direct this international public-private consortium of scientists.

To access the full article :

November 20, 2012 : FDA approves pump for heart failure patients awaiting heart transplant

The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a left ventricular assist device (LVAD), to support heart function and blood flow in patients with end-stage heart failure who are awaiting a heart transplant. An LVAD is a mechanical pump used to support heart function and blood flow in people who have weakened hearts. LVADs are the most common type of ventricular assist devices, and they help the heart’s left ventricle pump oxygen-rich blood to the body. The HeartWare System includes an implantable pump with an external driver and power source. It is designed for use inside or outside the hospital.

To access the full article :

November 27, 2012 : NIH-funded researchers show possible trigger for MS nerve damage

High-resolution real-time images show in mice how nerves may be damaged during the earliest stages of multiple sclerosis. The results suggest that the critical step happens when fibrinogen, a blood-clotting protein, leaks into the central nervous system and activates immune cells called microglia. "We have shown that fibrinogen is the trigger," said Katerina Akassoglou, Ph.D., an associate investigator at the Gladstone Institute for Neurological Disease and professor of neurology at the University of California, San Francisco, and senior author of the paper published online in Nature Communications.

To access the full article :


November 1, 2012 : New Finding Helps Explain Antibiotic Resistance in Staphylococcus aureus

Researchers at the Institut Pasteur, the CNRS, and the University of Tsukuba Faculty of Medicine (Japan) have proven for the first time that activating a specific gene in Staphylococcus aureus enables it to incorporate extracellular DNA and develop resistance to methicillin. They have also identified two mechanisms for the activation of the gene in question. These results represent an important step forward in the understanding of antibiotic resistance gene acquisition by S. aureus. This research was published in the journal PLoS Pathogens on November 1, 2012.

To access the full article :

November 8, 2012 : Two new emperor penguin colonies in Antarctica

While about 2500 chicks of emperor penguins are raised this year at the colony close to the French Dumont d’Urville Station, two new colonies totalling 6000 chicks have just been observed about 250 km away, near Mertz Glacier by the scientists Dr André Ancel and Dr Yvon Ancel, from the Institut Pluridisciplinaire Hubert Curien in Strasbourg (CNRS and Université de Strasbourg). Since a pair of emperor penguins may only successfully raise one chick a year, the population of breeding emperor penguins in this area of the Antarctic can therefore be estimated to more than about 8500 pairs, about three fold that previously thought.

To access the full article :

November 8, 2012 : Like coffee, blue light keeps night drivers alert

When driving at night, drowsiness brought about by sleep deprivation reduces a driver’s alertness, reflexes and visual perception. Sleepiness is responsible for one third of fatalities on motorways. Apart from taking a nap, which is often impractical, drinking coffee remains the best preventive measure. However, this forces drivers to stop, which they often leave too late. For road safety purposes, it is therefore essential to develop an “embedded” anti-sleepiness device working continuously. Blue light is known to increase alertness by stimulating retinal ganglion cells : specialized nerve cells present on the retina, a membrane located at the back of the eye. These cells are connected to the areas of the brain controlling alertness.

To access the full article :

November 13, 2012 : A sonar vision system for the congenitally blind

A "sonar vision" system enabling the congenitally blind to perceive the shape of a face, a house, and even letters and words is being developed by a team at Jerusalem’s Hebrew University. Using this device, the researchers have shown that the areas of the cerebral cortex normally devoted for reading become activated under the influence of stimuli in individuals blind from birth. The results of this study, conducted in collaboration with researchers at the Institute of the Brain and Spinal Cord (Inserm/UPMC/AP-HP) and NeuroSpin (CEA-Inserm) Research Centre, were published on 8th November in the journal Neuron.

To access the full article :

November 13, 2012 : Natural anesthetic in honeybee bites

Several hypotheses have been made about the function of 2-heptanone (2-H), a natural compound present in many foodstuffs and in insects, but its anesthetic properties were previously unknown. Results now show that 2-H, secreted by honeybee mandible glands, can paralyze small arthropods bitten by the bees, for up to nine minutes. Like a snake, a honeybee can use its mandibles to bite a foe and secrete the substance into the wound, paralyzing it. The bees can then throw the intruder out of their nest. This approach is particularly efficient against predators and parasites that are too small to be stung and killed with venom. But this anesthetic, which helps honeybees repel pests that attack their colonies – such as the wax moth Galleria mellonella and parasitic mite Varroa destructor – also has enormous potential in human medicine.

To access the full article :

November 16, 2012 : A new factor of genetic susceptibility to Alzheimer’s disease discovered through a study of a rare disease

A large-scale international study involving French researchers from the Inserm-Institut Pasteur Lille-Université Lille Nord de France “Public health and molecular epidemiology of ageing-related diseases” joint research unit led by Philippe Amouyel, has just discovered a gene for susceptibility to a rare disease that causes susceptibility to a common one, Alzheimer’s disease, providing evidence of the heterogeneous aetiology of Alzheimer’s disease. This whole-exome sequencing approach is explained in detail in The New England Journal of Medicine dated 14 November 2012.

To access the full article :

November 26, 2012 : Second Pléiades satellite to launch 1 December

With its great agility, quick-response ground segment and daily revisit capability, the Pléiades system developed by CNES is designed to acquire a new generation of “real-world” satellite Earth imagery with a resolution of 70 cm. The system’s 2nd satellite is all set to lift off on 1 December atop a Soyuz launch vehicle from the Guiana Space Centre into the same 694-km orbit as its twin Pléiades-1A, which has been sending back compelling views of the globe for almost a year now.

To access the full article :




Inorganic-Electrochemistry Seminar
"High-Valent Iron : Synthesis, Spectroscopy, and Reactivity"
December 3, 2012 4:00 pm
147 Noyes, J. Holmes Sturdivant Lecture Hall
Featured speakers : Lawrence Que, Jr. (University of Minnesota)
For further information, please contact Patricia Anderson
pea@its.caltech.edu at 6022

Center for the Chemistry of Cellular Signaling Seminar Series
Photochemical Triggering of Ion Channel Gating
December 6, 2012 12:00 pm
151 Crellin
Featured speakers : Oliver Shafaat, (California Institute of Technology)
For further information, please contact Anna Arnold
anordstr@caltech.edu at 3202

General Biology Seminar
Solving the antibody paradox : the diverse roles of Fc receptors in immunity
December 11, 2012 4:00 pm
119 Kerckhoff
Featured speakers : Jeffrey Ravetch, Eugene Lang (The Rockefeller University)
For further information, please contact Julia Boucher jboucher@caltech.edu at 4952


The von Kármán Lecture Series : 2012
GRAIL Unwraps the Moon
December 6, 2012 7:00 pm
The von Kármán Auditorium at JPL
4800 Oak Grove Drive, Pasadena, CA

December 7, 2012 7:00 pm
The Vosloh Forum at Pasadena City College
1570 East Colorado Blvd, Pasadena, CA
Featured speaker : Dr. Sami Asmar (GRAIL Deputy Project Scientist, JPL)


Symposium on the Interface between Cellular and Organismal Aging
December 13, 2012 9:30 am
Glenn Center for Aging Research at the Salk Institute
Featured speakers : Steven N. Austad (University of Texas), Lenhard Rudolf (Leibniz Institute), Cynthia Kenyon (University of California, San Francisco) and more


Microbiology and Molecular Genetics Seminar
December 5, 2012 4 pm
Tamkin Student Lecture Building, Room F-114
Featured speakers : Ian Clarke (University of Southhampton)
For further information, please contact myv@uci.edu or 949.824.7669

Human Neural Stem Cells in a SOD-1 Model of Motor Neuron Disease
December 7, 2012 11:00 am – 12:00 pm
Sue & Bill Gross Hall, 4th Floor
Featured speakers : Vassilis Koliatsos (Johns Hopkins University)
For further information, please contact stemcell@research.uci.edu or 949.824.9621


BRI Neuroscience Poster Session
December 4, 2012 1:00 pm - 5:30 pm
Ackerman Union Venue, Grand Ballroom (2400)
For further information, please contact (310) 825-5061, lmaninger@mednet.ucla.edu

UC Riverside

Biomimetic Strategies to Tissue Regeneration
December 5, 2012 11:10 a.m. – Noon
Chung Hall (formerly Engineering 2) 205/206
Featured speaker : Dr. Benjamin M. Wu (UCLA)
For further information, please contact Dr. Dimitrios Morikis, 951-827-2696, dmorikis@engr.ucr.edu


Rheumatology, Allergy and Immunology Seminars Series (RAIS)
December 10, 2012 12:30 pm
Leichtag Biomedical Research Building, Room 107
Featured speaker : Wendy L. Havran (The Scripps Research Institute)
For further information, please contact Marcia da Silva, (858) 534-2359, raidivision@ucsd.edu


The Five Misconceptions about Cancer
Health Speaker Series
December 13, 2012 4:30pm - 7:00pm
Indian Wells Country Club Wellness Center
Featured speakers : Michael Wong, M.D., Ph.D.
For further information, please contact erinwill@usc.edu (213) 740-6274


Please consult Le Fil de Marianne for further information on international calls and job offers.


Le Fil de Marianne
Le Fil de Marianne est une publication hebdomadaire des bureaux de l’INSERM et du CNRS aux Etats-Unis. Il offre une information détaillée sur les évolutions de la politique de recherche française, les appels d’offres et les manifestations scientifiques en France. L’abonnement est gratuit.

Les bulletins électroniques
Les articles et les rapports produits par les activités de veille scientifique menées par les Missions Scientifiques et Technologiques dans 40 zones géographiques sont accessibles gratuitement via les Bulletins Electroniques. Ils sont édités par l’Agence pour la Diffusion de l’Information Technologique (ADIT), sur une base mensuelle ou hebdomadaire.

Le service scientifique du Consulat Général de France à Los Angeles
Des informations sur le rôle de notre service au sein de la Mission pour la Science et la technologie (MS&T) peuvent être trouvées sur le site du Consulat Général de France à Los Angeles. Le planning des événements à venir ainsi que nos coordonnées, sont également disponibles en ligne.

Ce site offre des informations en Français sur l’actualité médicale et de la santé en France. Il propose une revue de presse quotidienne, consultable en ligne ou par newsletter, des articles et des comptes rendus de congrès médicaux. L’inscription (gratuite) est nécessaire pour accéder au contenu.

Newsletter du Genopole
Genopole est un pôle de compétitivité français spécialisé dans les biotechnologies et les biothérapies. La newsletter comprend des informations sur les appels à projets, les actions et les services offerts par le pôle.

Newsletter Alsace-Biovalley
Alsace BioValley est un pôle de compétitivité français spécialisé dans les sciences de la vie et santé. La newsletter comprend des informations sur les appels à projets, les actions et les services offerts par le pôle.

Newsletter LyonBioPole
LyonBioPole est un pôle de compétitivité français spécialisé dans les vaccins et le diagnostic. La newsletter comprend des informations sur les appels à projets, les actions et les services offerts par le pôle.

Newsletter Medicen
Medicen est un pôle de compétitivité français situé en région parisienne, spécialisé dans la médecine translationnelle, les outils biologiques et la bio-numérique. La newsletter comprend des informations sur les appels à projets, les actions et les services offerts par le pôle.

Newsletter EuroBiomed
EuroBiomed est un pôle de compétitivité français spécialisé dans le domaine de la santé et des sciences de la vie et couvrant les régions PACA et Languedoc-Roussillon. La newsletter comprend des informations sur les appels à projets, les actions et les services offerts par le pôle.

Newsletter Cancer-Bio-Santé
Cancer-Bio-Santé est un pôle de compétitivité français spécialisé dans le domaine de la nutrition et de l’innovation pharmaceutique et du suivi des patients. La newsletter comprend des informations sur les appels à projets, les actions et les services offerts par le pôle.


Scitizen.com offers free access to more than 1200 articles in English, written by scientists for the general public, in various scientific fields.

Biosmartbrief is a newsletter service, offering information in the fields of biotechnology, pharmaceutical sciences and business. Register for free to receive a daily news update.

Bilat-USA and Link-2-US
These two programs have been created to offer an easy access to information regarding collaboration between the US and Europe. Online articles and a newsletter service are available


We value your feedback. Please send us your comments and suggestions at deputy-sdv.la@ambascience-usa.org.

Please also check the following websites and newsletters for more information on the activities of the Consulate General of France in Los Angeles :


Subscribe to the monthly French arts and culture newsletter to receive information about shows, exhibitions and much more, by sending an email to : culture@consulfrance-losangeles.org


Subscribe to the monthly French Film and TV newsletter to receive information about projections and events, by sending an email to : frenchfilminla@consulfrance-losangeles.org



You can also register here to receive emails about events organized by the OST LA.

Dernière modification : 23/02/2016

Haut de page